Atropisomerism in Drug Discovery and Development
Date: 21 February 2023
Time: 15:00 (GMT), 16.00 (CET), 10.00 (ET), 7.00 (PT)
Tutors: Dr John Studley
Let’s Twist Again! Atropisomerism in Drug Discovery and Development
Atropisomerism is defined as conformational chirality originating from restricted rotation around a sigma-bond. Frequently encountered in hindered biaryl or heteroaryl systems, the combination of configurational stability and unique stereochemical architectures has been leveraged in the discovery and development of single atropisomers as both experimental and marketed drugs. In this webinar I will discuss the origin and structural characteristics of atropisomers, their application in drug discovery, and the challenges involved in their clinical development.
This webinar will be presented by Dr John Studley, Scientific Update at the following time:
15.00 GMT (UK, Lisbon)
16.00 CET (Paris, Madrid, Frankfurt etc)
10.00 ET (New York, Boston)
7.00 PT (San Francisco, LA)
If you are unable to attend on the day, do not worry, all registrants will be sent links to the recorded session and slides presented afterwards. Registrants who attend the ‘live’ session will receive an e-Certificate of Attendance.